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Mammalian embryonic development is regulated by several cytokines and growth factors from embryonic or maternal origins.
Since CSF-1 plays important role in embryonic development and implantation, we investigated its role in gram-negative bacterial
LPS-induced implantation failure. The eﬀect of LPS on normal (nonsuperovulated) and superovulated in vivo-produced embryos
was assessed by signs of morphological degeneration. A signiﬁcantly similar number of morphologically degenerated embryos
recovered from both nonsuperovulated and superovulated LPS treated animals on day 2.5 of pregnancy onwards were morpho-
logically and developmentally abnormal as compared to their respective controls (P<. 001. Normal CSF-1 expression level and
pattern were also altered through the preimplantation period in the mouse embryos and uterine horns after LPS treatment. This
deviation from the normal pattern and level of CSF-1 expression in the preimplantation embryos and uterine tissues suggest a role
for CSF-1 in LPS-induced implantation failure.
Copyright © 2006 Yogesh Kumar Jaiswal et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
A variety of cell types at the blastocyst implantation site pro-
duce growth factors that could play important role(s) in the
implantation process. Decidual cells and/or embryos pro-
duce transforming growth factor alpha (TGF-alpha), epi-
dermal growth factor (EGF), platelet-derived growth factor
(PDGF), ﬁbroblast growth factor (FGF), and colony stim-
ulating factor (CSF-1) (Haimovici et al [1]). Furthermore,
receptors for EGF, PDGF, and CSF-1 have been detected on
embryonic and trophoblast cells. The receptor for CSF-1 (c-
fms)hasbeendetectedfromtheearly2-cellstageembryoon-
wardsalbeitatlowlevels.CSF-1mRNAtranscriptshavebeen
detectedintheoviductsanduterussuggestingaparacrineac-
tion of these growth factors during the preimplantation pe-
riod of embryonic development (Arceci et al [2]).
During pregnancy, a paradoxical relationship exists be-
tween the fetal allograft and the maternal immune system.
Several studies have demonstrated the adverse and beneﬁcial
eﬀects of cytokines and growth factors secreted by activated
lymphocytes and monocytes on the development of early
embryos, during pathogenic conditions. These evidences
have now formed the basis of the “immunotrophism” hy-
pothesis, which suggests that local cytokines and growth
factors produced by activated immune cells promote preg-
nancy. Colony stimulating factor-1 (or CSF-1, also known
as macrophage colony stimulating factor, M-CSF) is found
in humans as a 90kd secreted homodimer and a 86kd
membrane-bound form, which is cleaved to release a 46kd
homodimer (Rettenmeir et al [3]). It has been shown that
CSF-1 mRNA and its corresponding protein increase 1000
folds in the uterine horns during pregnancy in mouse
(Pollard [4]). CSF-1 protein and CSF-1 mRNA expression
also increase in the placenta in human with advancing ges-
tation (Kauma et al 1999).
Adequate knowledge on preimplantation embryogenesis
is necessary for the successful accomplishment of medically
assisted reproductive technology and for embryo biotech-
nology (Iritani [5]). For carrying out the various embry-
onic manipulations in vitro, usually, a large number of viable
andsynchronouslydevelopingembryosarerequiredandthat
can be obtained by superovulation. Silent subclinical gram-
negative bacterial infections of the genital tract of pregnant
animals may lead to poor quality of collected embryos. We2 Infectious Diseases in Obstetrics and Gynecology
designedthepresentstudytoevaluatethedevelopmentalsta-
tus of preimplantation embryos developing in vivo in LPS-
treated pregnant animals under nonsuperovulated/normal
and superovulated conditions.
Gram-negative bacterial infections of the genitourinary
tract of pregnant women are known to cause abortion, fe-
tal loss, or poor pregnancy outcome (for a review see Deb et
al [6]). Gram-negative bacterial endotoxins, lipopolysaccha-
rides (LPS) is the main antigenic component of the gram-
negative bacterial cell wall, and is known for its potency to
activate the myeloid and nonmyeloid cells to produce cy-
tokines. These cytokines and growth factors exert autocrine
and paracrine eﬀects on the surrounding cells and modulate
the expression and synthesis of other cytokines. Silent sub-
clinical infections of these bacteria can lead to early preg-
nancy losses where the mother remains unaware of it (see
D e be ta l[ 7]). In a previous study we have established the
“minimum dose” of LPS which can compromise blastocyst
implantation in mouse (Deb et al [8]). The objectives of this
study were to ﬁnd out if LPS could alter the pattern and
level of mRNA expression of CSF-1 in the 2-cell to blastocyst
stage embryos and uterine horns at narrow intervals over the
preimplantation period of pregnancy in mouse.
MATERIAL AND METHODS
Superovulationandembryorecovery
Park strain mice were maintained, superovulated, and mated
as described earlier (Deb et al [9, 10]). Female mice were
killed by cervical dislocation on days 1.5, 2.5, 3.5, 4.0, 4.125,
4.25, 4.3, and 4.42 of the preimplantation period of preg-
nancy.Theembryoswererecoveredoneachdayofpregnancy
by ﬂushing the excised oviducts and uterine horns with ster-
ile PBS in sterile endotoxin free petri-dishes (Deb et al [10]).
The recovered embryos were examined under a microscope
(Nikon, Japan) and their morphology was studied using 20X
and 40X objectives.
Effectofthe“minimumeffectivedose”ofLPSon
developmentofpreimplantationstageembryos
collectedfromnonsuperovulated/normaland
superovulatedpregnantanimals
The “minimum eﬀective dose” of LPS was given through
IP route to normal and superovulated pregnant females on
day 0.5 of pregnancy. The control animals were treated with
equal volume of normal saline. The animals were sacriﬁced
by cervical dislocation on days 1.5, 2.5, 3.5, and 4.375 of
pregnancy and preimplantation stage embryos were recov-
ered separately by ﬂushing oviducts/uterus collected from
control and LPS-treated animals of both the groups with
PBS in endotoxin free petri-dishes. The embryos recovered
fromLPS-treatedanimalsofboththegroupsduringdiﬀerent
stages of preimplantation period of pregnancy were counted
and examined under a microscope (Nikon, Japan) for visible
morphological abnormalities and compared with that of the
respective control.
EffectofLPSonexpressionofCSF-1inembryos
anduteruscollectedatdifferentstagesof
preimplantationperiodofpregnancy
The experiments were performed to study the eﬀect of LPS
on the expression of CSF-1 in embryos and uterus collected
atdiﬀerentstagesofpreimplantationperiod(ie,days1.5,2.5,
3.5,4.0,4.125,4.25,4.33,and4.42)ofpregnancybyRT-PCR.
Park strain mice (6-7 weeks) were superovulated with PMSG
and hCG as per the protocol. A “minimum dose” of LPS (ie,
5μg/animal) in 100μL of sterile normal saline (determined
in a previous study) was injected to each pregnant animal
throughIProuteonday0.5ofpregnancy(Debetal[8]).The
control animals received 100μL of sterile normal saline in a
similar manner. The animals of both groups were sacriﬁced
at narrow intervals of the preimplantation period (ie, days-
1.5, 2.5, 3.5, 4.0, 4.125, 4.25, 4.33, and 4.42) of pregnancy
to collect the embryos and uterine horns. A total of about
500embryoswerecollectedateachtimetodetectthepositive
mRNA signals for CSF-1 by RT-PCR.
ExtractionoftotalRNAfromuterusandembryos
andsemiquantitativeRT-PCR
Total RNA was extracted from the embryos and uterine
horns as described earlier (Deb et al [8]). The reverse tran-
scription polymerase chain reaction (RT-PCR) was carried
outusing“TitanOnetubeRT-PCRSystem”(M/SBoehringer
Mannheim, Germany). It was carried out as per the in-
structions provided by the manufacturer. The upstream
and downstream primers for CSF-1 were initially purchased
from M/S Clontech, USA, and later synthesized from M/S
Genset Singapore Biotech Pte Ltd, Singapore. The primers
for β-actin were synthesized from M/S Genset Singapore
Biotech Pte Ltd, Singapore, and were used as internal control
throughouttheexperiments(Weihuaetal[11]).Theprimers
used were 5 -CGGGCATCATCCTAGTCTTGCTGACTGT-
T-3  plus 5 -AAATAGTGGCAGTATGTGGGGGGGCATC-
CT-3  and 5 -GGGCACAGTGTGGGTGAC-3  plus 5 -CT-
GGCACCACACCTTCTAAC-3  for β-actin.
Statisticalanalyses
Statistical analyses were performed using one-way analysis
of variance (ANOVA) with Duncan’s multiple range test for
comparison of the signiﬁcance level (P) between control and
treated values. A P<. 05 value was considered as signiﬁcant
diﬀerence between the values compared.
RESULTS
Effectofthe“minimumdose”ofLPSondevelopment
ofpreimplantationstageembryoscollectedfrom
nonsuperovulated/normalpregnantanimals
The embryos were recovered from reproductive tracts of
control and LPS-treated animals during diﬀerent stages
of preimplantation period (ie, from day 1.5t o4 .375) ofYogesh Kumar Jaiswal et al 3
Table 1: Eﬀect of the “minimum eﬀective dose” of LPS on development of preimplantation stage embryos collected from nonsuperovulated
pregnant animals. Data is expressed as mean ± 1SEM, with all values given in (%) of abnormal embryos. Means bearing similar superscripted
alphabets do not diﬀer from each other at P ≤ .05 (based on Duncan’s multiple range test). ANOVA: treatment (T), F-value = 304.354
(P<. 001), df 1,16; days of pregnancy (P), F-value = 42.761 (P<. 001), df 3,16; T × P interaction F-value = 36.881 (P<. 001), df 3,16.
Days of
pregnancy
No of
animals
used
Control animals LPS-treated animals
Total no of
embryos
recovered
No of
abnormal
embryos
recovered
Loss in
yield (%)
Abnormal
embryos (%)
Total no of
embryos
recovered
No of
abnormal
embryos
recovered
Loss in
yield (%)
Abnormal
embryos (%)
1.5 3 27 ±20 ±20 4 ±2(e) 27 ±20 ±204 ±2.17(e)
2.5 3 27 ±20 ±20 4 ±2.18(e) 23 ±21 5 ±21 5 6 5 ±5.022(b)
3.5 3 27 ±22 ±10 7 ±2.027(c) 20 ±21 5 ±32 6 7 5 ±8.66(b)
4.375 3 27 ±22 ±10 7 ±2.027(c) 6 ±36 ±17 8 9 4 ±5.56(a)
pregnancy to assess the eﬀect of LPS on preimplantation em-
bryonic development.
Day1.5ofpregnancy
Developmentally normal 2-cell stage embryos were recov-
ered from oviducts of control and LPS-treated animals on
day 1.5 of pregnancy (Figures 1(a), 1(e)). The average num-
bers of embryos collected from control and LPS-treated an-
imals were found to be the same. Moreover, equal number
of abnormal embryos was recovered from control and LPS-
treated animals (Table 1).
Day2.5ofpregnancy
The embryos recovered from oviducts of control animals
on day 2.5 of pregnancy were normal and were at 4–8 cell
stage of development (Figure 1(b)). However, developmen-
tally arrested and apoptotic embryos with fully and/or par-
tially degenerated blastomeres were recovered from oviducts
of LPS-treated animals (Figure 1(f)). It was also observed
that 4 ± 2.18% and 65 ± 5.022% of embryos collected from
control and LPS-treated animals, respectively, were develop-
mentally abnormal (Table 1). The average number of em-
bryos retrieved from LPS-treated animals also declined by
15% as compared to that of the control (Table 1). A signif-
icant increase in the number of abnormal embryos recovered
was observed from LPS-treated animals as compared to that
of the control (P<. 05).
Day3.5ofpregnancy
The embryos were recovered from uterus instead of oviducts
of control and LPS-treated animals on day 3.5o fp r e g -
nancy. The embryos recovered from control animals were at
the morula stage of development. However, asynchronously
cleavedanddegeneratedembryoswithclearsignofapoptotic
bodies were recovered from LPS-treated animals (Figures
1(c), 1(g)). It was observed that 7 ± 2.207% and 75 ± 8.66%
of embryos retrieved from control and LPS-treated animals,
respectively, were developmentally abnormal (Table 1). The
number of embryos that was recovered on this day of preg-
nancy from LPS-treated animals was further reduced to 26%
as compared to that of the control.
A signiﬁcant increase in number of abnormal embryos
recovered was observed from LPS-treated animals as com-
pared to that of the control (P<. 05, Table 1). However,
no signiﬁcant diﬀerence in collected abnormal embryos was
foundfromanimalstreatedwithLPSonday3.5ofpregnancy
as compared to that on day 2.5o fp r e g n a n c y .
Day4.375ofpregnancy
The embryos recovered from control animals on day 4.375 of
pregnancy were at blastocyst stage of development with in-
tact zona pellucida (ZP) and only 7±2.207% of the collected
embryos were developmentally abnormal (Figure 1(d)).
However, 94 ± 5.56% of total embryos retrieved from LPS-
treated animals were degenerated/fragmented and without
ZP (Figure 1(h)). The average number of embryos recovered
from LPS-treated animals was reduced as compared to that
of the control. Therefore, 78% of embryonic loss was ob-
servedinLPS-treatedanimalsascomparedtothatofthecon-
trol on this day of pregnancy (Table 1). A signiﬁcant increase
in number of developmentally abnormal embryos recovered
was observed from LPS-treated animals as compared to that
of the control (P<. 001). A signiﬁcant increase in number
of abnormal embryos recovered from LPS-treated animals
was observed with increase in length of gestational period as
compared to that of the control (P<. 001, Table 1).
Effectofthe“minimumdose”ofLPSondevelopment
ofpreimplantationstagesuperovulatedembryos
collectedfrompregnantanimals
The embryos were collected from reproductive tracts of su-
perovulated control and LPS-treated pregnant animals dur-
ing diﬀerent stages of preimplantation period (ie, from day
1.5t o4 .375) of pregnancy to assess the eﬀect of LPS on
preimplantation embryonic development in superovulated
pregnant animals.4 Infectious Diseases in Obstetrics and Gynecology
(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 1:PhotographofembryosrecoveredfromcontrolandLPS-treatednonsuperovulatedpregnantmiceduringdiﬀerentstagesofpreim-
plantation period of pregnancy. Panels (a), (b), (c), and (d) show embryos recovered from control animals on days 1.5, 2.5, 3.5, and 4.375 of
pregnancy, respectively. Panels (e), (f), (g), and (h) show embryos recovered from the animals treated with the “minimum dose” of LPS on
days 1.5, 2.5, 3.5, and 4.375 of pregnancy, respectively, X100.
Day1.5ofpregnancy
An average of 29 ± 5 embryos was harvested from super-
ovulated control and LPS-treated animals on day 1.5o f
pregnancy. The recovered superovulated embryos from both
groups of animals were normal and were at 2-cell stage of de-
velopment (Figures 2(a), 2(e)). No signiﬁcant diﬀerences in
the quantity of developmentally abnormal embryos were ob-
served in the total embryos recovered from control and LPS-
treated pregnant animals on this day of pregnancy (Table 2).
Day2.5ofpregnancy
The embryos recovered from oviducts of control animals
on day 2.5 of pregnancy were normal and were at 4–8 cell
stage of development (Figure 2(b)). However, developmen-
tally arrested and apoptotic embryos with fully or partially
degenerated blastomeres were recovered from oviducts of
LPS-treated animals (Figure 2(f)). The average yield of su-
perovulated embryos from control and LPS-treated animals
was found to be similar on this day of pregnancy as com-
pared to the previous day of pregnancy. However, a signif-
icant increase in the number of developmentally abnormal
embryos recovered was observed from LPS-treated animals
as compared to that of the control (P<. 05, Figures 2(b),
2(f); Table 2). A signiﬁcant increase in the number of devel-
opmentally abnormal embryos recovered from control and
LPS-treated animals on this day of pregnancy was observed
as compared to the embryos recovered from the previous day
of pregnancy.
Day3.5ofpregnancy
The embryos were recovered from the uterus instead of
oviduct of control and LPS-treated animals on day 3.5o f
pregnancy. The number of embryos harvested on this day of
pregnancy from both groups of animals was similar as com-
pared to the previous days of pregnancy. The normal em-
b r y o sr e c o v e r e df r o mc o n t r o la n i m a l sw e r ea tm o r u l as t a g e
of development. However, about half of the total embryos
collectedfromLPS-treatedanimalsweredevelopmentallyar-
rested, degenerated, and fragmented (Figures 2(e), 2(g)). A
signiﬁcant increase in the number of developmentally ab-
normal embryos recovered was observed from LPS-treated
animals as compared to that of the control (P<. 05, Table 2).
However,thenumberofdevelopmentallyabnormalembryos
from control and LPS-treated animals on this day of preg-
nancy did not diﬀer signiﬁcantly from the previous day of
pregnancy.
Day4.375ofpregnancy
The embryos recovered from control animals on day 4.375
of pregnancy were at blastocyst stage of development withYogesh Kumar Jaiswal et al 5
(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 2: Photograph of embryos recovered from control and LPS-treated superovulated pregnant mice during diﬀerent stages of preim-
plantation period of pregnancy. Panels (a), (b), (c), and (d) show embryos recovered from control animals on days 1.5, 2.5, 3.5, and 4.375 of
pregnancy, respectively. Panels (e), (f), (g), and (h) show embryos recovered from the animals treated with the “minimum dose” of LPS on
days 1.5, 2.5, 3.5, and 4.375 of pregnancy, respectively, X100.
Table 2: Eﬀect of the “minimum eﬀective dose” of LPS on development of preimplantation stage embryos collected from superovulated
pregnant animals. Data is expressed as mean ± 1SEM, with all values given in (%) of abnormal embryos. Means bearing similar superscripted
alphabets do not diﬀer from each other at P ≤ .05 (based on Duncan’s multiple range test). ANOVA: treatment (T), F-value = 959.694
(P<. 001), df 1, 24; days of pregnancy (P), F-value = 251.514 (P<. 001), df 3,24; T ×P interaction F-value = 195.104 (P<. 001), df 3,24.
Days of
pregnancy
No of
animals
used
Control animals LPS-treated animals
Total no of
embryos
recovered
No of
abnormal
embryos
recovered
Loss in
yield (%)
Abnormal
embryos (%)
Total no of
embryos
recovered
No of
abnormal
embryos
recovered
Loss in
yield (%)
Abnormal
embryos (%)
1.5 4 116 ±50 ±50 2 ±1.199(e) 116 ±50 ±60 3 ±1.472(e)
2.5 4 116 ±51 2 ±50 9 ±1.914(d) 116 ±54 8 ±50 4 2 ±1.658(b)
3.5 4 116 ±51 6 ±50 1 3 ±2.179(d) 116 ±55 6 ±60 4 8 ±2.041(b)
4.375 4 104 ±58 ±41 0 8 ±2.027(c) 72 ±56 4 ±43 8 9 2 ±5.566(a)
intact zona pellucida (ZP) and only 8 ± 2.027 of the col-
lected embryos were developmentally abnormal (Figures
2(d), 2(h)). However, the total number of recovered em-
bryos declined by 10% as compared to that of the earlier days
of pregnancy. The embryos recovered from LPS-treated an-
imals were shrunken and without ZP. Moreover, the yield
of embryos recovered was decreased by 38% as compared
to that of the earlier days of pregnancy. It was found that
92±5.566% ofthetotalembryosrecoveredfromLPS-treated
animals were developmentally abnormal as compared to that
of the control (Table 2). A signiﬁcant increase in the num-
berofdevelopmentallyabnormalembryosrecoveredwasob-
served from LPS-treated animals as compared to that of the
control (P<. 05, Table 2). A signiﬁcant increase in the num-
ber of recovered abnormal embryos from LPS-treated ani-
mals was observed on this day of pregnancy as compared to
the previous day of pregnancy. Moreover, a signiﬁcant in-
crease in the number of abnormal embryos recovered from6 Infectious Diseases in Obstetrics and Gynecology
LPS-treated animals was observed with increase in length of
gestationperiodascomparedtothatofthecontrol(P<. 001,
Table 2).
ExpressionofCSF-1inpreimplantation
embryosanduterinehorns
An average of 29 ± 5 embryos per pregnant animal was col-
lected after superovulation. In the present study, about 500
embryos recovered during diﬀerent stages of the preimplan-
tation period (ie, days 1.5, 2.5, 3.5, 4.0, 4.125, 4.33, and 4.42)
of pregnancy from control and LPS-treated animals were
used each time to study the expression of CSF-1/M-CSF by
RT-PCR. Positive mRNA signal of CSF-1 was observed in de-
velopingembryoscollectedfromcontrolandLPS-treatedan-
imals from day 1.5t od a y3 .5 of gestation period (ie, from
2-cell stage to the morula stage) (Figures 3(a), 3(b)). How-
ever, an abrupt expression of this gene was again observed
in embryos collected from LPS-treated animals on day 4.42
of pregnancy (Figure 3(a)). A uniform expression of β-actin
genewasobservedintheembryoscollectedfromcontroland
LPS-treatedanimalsduringdiﬀerentdevelopmentalstagesof
preimplantation period of pregnancy (Figure 3(c)).
TheuterinehornscollectedfromcontrolandLPS-treated
animals during diﬀerent stages of the preimplantation pe-
riod of pregnancy (ie, days 1.5, 2.5, 3.5, 4.0, 4.125, 4.33,
and 4.42 of pregnancy) were used to study the expression
of proinﬂammatory cytokines and growth factors CSF-1 by
RT-PCR. Expression of CSF-1 mRNA increased gradually in
uterine horns collected from control animals from day 1.5o f
pregnancy till implantation (Figure 4(b)). In uterine horns
from LPS-treated animals CSF-1 expression decreased be-
tween day 3.5t o4 .125 of pregnancy as compared to that of
the control. However, its mRNA expression resumed back to
normal levels (equivalent to control) from day 4.25 of preg-
nancy onwards till implantation (Figures 4(a), 4(b)). A uni-
form expression of β-actin gene was obtained in the uterus
collected from control and LPS-treated animals during dif-
ferent developmental stages of pregnancy (Figure 4(c)).
DISCUSSION
It has been shown that the pathophysiology of microbial in-
fection that induced pregnancy loss in mouse is similar to
that in human. Therefore, mouse may be used as a reliable
and reproducible animal model to elucidate the molecular
mechanisms of failure of pregnancy (Dudley et al [12]). To
elucidate the mechanism of LPS-induced failure of implan-
tation we investigated its eﬀect on the in vivo development
of preimplantation stage embryos collected from nonsuper-
ovulated/normal and superovulated pregnant animals. We
observed that the LPS had more or less similar eﬀects on
the quality and quantity of embryos collected from the non-
superovulated and superovulated animals. The abrupt de-
cline in the quality and quantity of the embryos in response
to LPS on day 4.375 of pregnancy may be one of the causes of
reduced reproductive eﬃciencies during gram-negative bac-
terial infections (Rupasri et al [13]).
The observed asynchronous cleavage and degeneration
of preimplantation embryos recovered from LPS-treated an-
imals may be due to activation of LPS-triggered apoptotic
pathwaysinthecellsofdevelopingpreimplantationembryos.
Zou et al [14] suggested that LPS triggers F as mediated
apoptotic pathway in mouse preimplantation (2-cell stage)
embryos. It has also been reported that the expression of
genes involved in cell death (eg, MA-3, p53, Bad, and Bcl-
xS etc) gets elevated and that of the genes involved in cell
survival (eg, Bcl-2) gets downregulated in embryos undergo-
ing fragmentation (Jurisicova et al [15]a n dL e v y[ 16]). The
presentstudyclearlydemonstratesthatLPSisassociatedwith
severe degeneration and fragmentation of mouse embryos in
vivo. This may be due to an early expression of several proin-
ﬂammatory cytokines in response to LPS in the developing
mouse embryos.
The early preimplantation stage embryos are maintained
in a nonadhesive state by a nonadhesive proteinaceous coat
of ZP (Foulk [17]). The ZP prevents the attachment of the
prematured embryo to the endometrium and also helps in
the transfer of the developing embryos from the oviducts to
theuterus(Carsonetal [18]).Thezonaisshedfromthesur-
faceofthematuredblastocystjustbeforeimplantation(ie,on
day 4.5 of pregnancy) under normal pregnancy and makes
it attachment-competent. However, we saw an early loss of
zona pellucida (on day 4.37 of pregnancy) from the devel-
oping embryos in response to LPS. The early loss of ZP may
expose the premature blastocyst to high levels of cytotoxic
factors, which may lead to the fragmentation and degenera-
tion of developing embryos in mouse.
This study clearly implies that the low dose of LPS used
in the present experiment may mimic the pathophysiology
of subclinical genital tract infection of gram-negative bac-
teria, which may not aﬀect the uterine preparation for em-
bryonic receptivity at the gross anatomical or physiological
levels. Our study also indicates that the preimplantation em-
bryonic development is susceptible to low level of LPS in
vivo. The present observations clearly demonstrate that LPS
signiﬁcantly aﬀects the morphology and development of the
superovulated embryos, which suggests the mouse embryos
produced in vivo may be a good model to study such compli-
cations. It is possible that the growth factors and cytokines
of embryonic and/or maternal origin, which are produced
in response to LPS may alter the molecular dialogue at the
feto-maternal interface, which may lead to poor pregnancy
outcome and infertility in mouse.
CSF-1 performs several functions during implantation
and placentation in physiological pregnancy. Bhatnagar et
al [19], in an in vitro study, have shown that CSF-1 stim-
ulates the development of trophectoderm of the blastocyst.
CSF-1 regulates growth, diﬀerentiation, and functions of
macrophages, is readily detectable in the peripheral blood in
the steady state, and is further induced in vivo after infection
(Cheers and Stanley [20]) or challenge with LPS (Roth et al
[21]). Furthermore, CSF-1 treatment in vivo increased levels
of LPS-induced TNF-α and IL-6 (Chapoval et al [22]).
WeobservedanearlyexpressionofCSF-1geneintheem-
bryos collected from the control animals. Our observationYogesh Kumar Jaiswal et al 7
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Figure 3: Detection of CSF-1 mRNA transcripts in the preimplantation mouse embryos collected from (a) LPS-treated animals and (b)
control animals at thediﬀerent stages of preimplantation period of pregnancy by RT-PCR.Pannel (c) shows arepresentative picture showing
uniform expression of β-actin used as an internal control.
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Figure 4: Detection of CSF-1 mRNA transcripts in the mouse uterine horns collected from (a) LPS-treated animals and (b) control animals
at the diﬀerent stages of preimplantation period of pregnancy by RT-PCR. Pannel (c) shows a representative picture showing uniform
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suggests its importance in the normal development of em-
bryos during the early preimplantation stages. Zolti et al
[23] reported the expression of CSF-1 in unfertilized human
oocytes and during early embryogenesis. However, Arceci et
al [2] could not detect its expression in preimplantation em-
bryos in mouse. The pattern of CSF-1 expression in the em-
bryosrecoveredfromLPS-treatedanimalswassimilar tothat
of the control during days 1.5t o3 .5o fp r e g n a n c y .H o w e v e r ,
its abrupt expression in blastocysts (day 4.33) in response to
LPSmayleadtoformationofdevelopmentallycompromised
blastocysts which are incompetent for implantation.
The increase in CSF-1 production after ovulation and
during pregnancy by uterine tissues as observed by us and
previous researchers (Pollard et al [4]) may be due to in-
creasing levels of progesterone, which is known to stimulate
in vitro production of M-CSF in endometrium (Azuma et al
[24]). The decreased level of CSF-1 mRNA in the uterus of
animals treated with LPS as compared to that of the control
a n i m a l so nd a y s3 .5, 4.0, and 4.125 of pregnancy indicates
that LPS may have a slight antiprogestrogenic activity. The
observed decrease in the expression of CSF-1, in the present
study, in response to the treatment of animals with LPS may
decrease uterine receptivity to the implanting blastocyst and
may lead to unsuccessful implantation.
The ability of LPS to induce a diﬀerential regulation of
the expression of CSF-1 in uterine horns and the preimplan-
tation embryos suggests the possibility that the expressions
of other cytokines like TNF and IL-6 were altered by CSF-1.
Though the data is semiquantitative in nature, to our knowl-
edge this is the ﬁrst report which shows a diﬀerential expres-
sion of CSF-1 in the uterine horns and preimplantation em-
bryos in response to LPS, and it highlights the importance
of a regulated expression of CSF-1 for sustenance of normal
pregnancy.
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